Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2021

18.02.2021 | Epidemiology

Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors

verfasst von: Kyae Hyung Kim, Seulggie Choi, Kyuwoong Kim, Jooyoung Chang, Sung Min Kim, Seong Rae Kim, Yoosun Cho, Yun Hwan Oh, Gyeongsil Lee, Joung Sik Son, Sang Min Park

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the association of physical activity among long-term breast cancer survivors on the occurrence of subsequent cardiovascular disease (CVD).

Methods

We investigated the risk of CVD among 39,775 breast cancer patients who were newly diagnosed in 2006 and survived until 2011 within the Korean National Health Insurance Service database. Patients were followed up from 5 years after breast cancer diagnosis to the date of CVD event, death, or December 31, 2018, whichever came earliest. Every 500 MET-mins/week correspond to 152, 125, and 62.5 min per week of light-, moderate-, and vigorous-intensity physical activity, respectively. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for CVD were calculated using Cox proportional hazards regression by physical activity levels.

Results

Compared with those with physical activity of 0 MET-min/week, those with 1–499 (aHR 0.82, 95% CI 0.69–0.98), 500–999 (aHR 0.75, 95% CI 0.63–0.90), and ≥ 1,000 (aHR 0.76, 95% CI 0.63–0.93) MET-min/week of PA had lower risk of CVD. Higher levels of PA were associated with lower risk of stroke (p for trend = 0.016). The benefits of PA on obese and overweight breast cancer survivors were smaller than those in normal weight survivors. The frequency of moderate-to-vigorous physical activity (MVPA) showed a reverse J-curve association with CVD, and the best benefit occurred in the 3–4 times MVPA per week group (aHR 0.59, 95% CI 0.46–0.74).

Conclusions

The study showed that even small amounts of PA may be beneficial in potentially decreasing the risk of CVD, CHD, and stroke in breast cancer survivors. Our result will be useful to prescribe and delivery exercise among long-term breast cancer survivors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Global Burden of Disease Cancer C et al (2019) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2019.2996CrossRef Global Burden of Disease Cancer C et al (2019) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. https://​doi.​org/​10.​1001/​jamaoncol.​2019.​2996CrossRef
2.
Zurück zum Zitat Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023–1075. https://doi.org/10.1016/s0140-6736(17)33326-3CrossRefPubMedPubMedCentral Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo ESG, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023–1075. https://​doi.​org/​10.​1016/​s0140-6736(17)33326-3CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS, American Heart Association, Cardiovascular Disease in W, Special Populations Committee of the Council on Clinical C, Council on C, Stroke N, Council on Quality of C, Outcomes R (2018) Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation 137(8):e30–e66. https://doi.org/10.1161/CIR.0000000000000556CrossRefPubMedPubMedCentral Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña IL, Volgman AS, American Heart Association, Cardiovascular Disease in W, Special Populations Committee of the Council on Clinical C, Council on C, Stroke N, Council on Quality of C, Outcomes R (2018) Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation 137(8):e30–e66. https://​doi.​org/​10.​1161/​CIR.​0000000000000556​CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, Perren T, Passalacqua R, Bighin C, Klijn JG, Ageev FT, Hitre E, Groetz J, Iwata H, Knap M, Gnant M, Muehlbauer S, Spence A, Gelber RD, Piccart-Gebhart MJ (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25(25):3859–3865. https://doi.org/10.1200/jco.2006.09.1611CrossRefPubMed Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, Perren T, Passalacqua R, Bighin C, Klijn JG, Ageev FT, Hitre E, Groetz J, Iwata H, Knap M, Gnant M, Muehlbauer S, Spence A, Gelber RD, Piccart-Gebhart MJ (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25(25):3859–3865. https://​doi.​org/​10.​1200/​jco.​2006.​09.​1611CrossRefPubMed
17.
Zurück zum Zitat Anulika Aweto H, Akinbo SR, Olawale OA (2015) Effects of Combined Aerobic and Stretching Exercises on the Cardiopulmonary Parameters of Premenopausal and Postmenopausal Breast Cancer Survivors. Nig Q J Hosp Med 25(3):177–183PubMed Anulika Aweto H, Akinbo SR, Olawale OA (2015) Effects of Combined Aerobic and Stretching Exercises on the Cardiopulmonary Parameters of Premenopausal and Postmenopausal Breast Cancer Survivors. Nig Q J Hosp Med 25(3):177–183PubMed
19.
Zurück zum Zitat Giallauria F, Vitelli A, Maresca L, Santucci De Magistris M, Chiodini P, Mattiello A, Gentile M, Mancini M, Grieco A, Russo A, Lucci R, Torella G, Berrino F, Panico S, Vigorito C (2016) Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 dietary intervention study. Intern Emerg Med 11(2):183–189. https://doi.org/10.1007/s11739-015-1259-8CrossRefPubMed Giallauria F, Vitelli A, Maresca L, Santucci De Magistris M, Chiodini P, Mattiello A, Gentile M, Mancini M, Grieco A, Russo A, Lucci R, Torella G, Berrino F, Panico S, Vigorito C (2016) Exercise training improves cardiopulmonary and endothelial function in women with breast cancer: findings from the Diana-5 dietary intervention study. Intern Emerg Med 11(2):183–189. https://​doi.​org/​10.​1007/​s11739-015-1259-8CrossRefPubMed
20.
Zurück zum Zitat Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE (2018) Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol 36(9):875–883. https://doi.org/10.1200/JCO.2017.75.7526CrossRefPubMedPubMedCentral Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE (2018) Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol 36(9):875–883. https://​doi.​org/​10.​1200/​JCO.​2017.​75.​7526CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, Lee EJ, Ae Shin S (2017) Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 46(3):799–800. https://doi.org/10.1093/ije/dyw253CrossRefPubMed Cheol Seong S, Kim YY, Khang YH, Heon Park J, Kang HJ, Lee H, Do CH, Song JS, Hyon Bang J, Ha S, Lee EJ, Ae Shin S (2017) Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 46(3):799–800. https://​doi.​org/​10.​1093/​ije/​dyw253CrossRefPubMed
29.
Zurück zum Zitat Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2019) Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139(10):e56–e528. https://doi.org/10.1161/CIR.0000000000000659CrossRefPubMed Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O’Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS, American Heart Association Council on E, Prevention Statistics C, Stroke Statistics S (2019) Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation 139(10):e56–e528. https://​doi.​org/​10.​1161/​CIR.​0000000000000659​CrossRefPubMed
38.
Zurück zum Zitat Vicent L, Ariza-Solé A, González-Juanatey JR, Uribarri A, Ortiz J, López de Sá E, Sans-Roselló J, Querol CT, Codina P, Sousa-Casasnovas I, Martínez-Sellés M, Arrest tC, registry MINAMOSe, (2018) Exercise-related severe cardiac events. Scand J Med Sci Sports 28(4):1404–1411. https://doi.org/10.1111/sms.13037CrossRefPubMed Vicent L, Ariza-Solé A, González-Juanatey JR, Uribarri A, Ortiz J, López de Sá E, Sans-Roselló J, Querol CT, Codina P, Sousa-Casasnovas I, Martínez-Sellés M, Arrest tC, registry MINAMOSe, (2018) Exercise-related severe cardiac events. Scand J Med Sci Sports 28(4):1404–1411. https://​doi.​org/​10.​1111/​sms.​13037CrossRefPubMed
40.
Zurück zum Zitat Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH (2019) Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc 51(11):2375–2390CrossRefPubMedPubMedCentral Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH (2019) Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc 51(11):2375–2390CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Centers for Disease C, Prevention (2013) Adult participation in aerobic and muscle-strengthening physical activities–United States, 2011. MMWR Morb Mortal Wkly Rep 62(17):326–330 Centers for Disease C, Prevention (2013) Adult participation in aerobic and muscle-strengthening physical activities–United States, 2011. MMWR Morb Mortal Wkly Rep 62(17):326–330
52.
Zurück zum Zitat Seo HJ, Oh I-H, Yoon S-J (2012) A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev 13(12):6163–6168CrossRefPubMed Seo HJ, Oh I-H, Yoon S-J (2012) A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pac J Cancer Prev 13(12):6163–6168CrossRefPubMed
Metadaten
Titel
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors
verfasst von
Kyae Hyung Kim
Seulggie Choi
Kyuwoong Kim
Jooyoung Chang
Sung Min Kim
Seong Rae Kim
Yoosun Cho
Yun Hwan Oh
Gyeongsil Lee
Joung Sik Son
Sang Min Park
Publikationsdatum
18.02.2021
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2021
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-021-06140-8

Weitere Artikel der Ausgabe 1/2021

Breast Cancer Research and Treatment 1/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.